SUPT5H and intrahepatic cholangiocarcinoma: Furthermore, the PIWIL4/SUPT5H complex has been identified as a promising prognostic biomarker for predicting clinical outcomes and immune microenvironment features in intrahepatic cholangiocarcinoma (54).